UK Vaccines Advisory Body Says Under 30s Shouldn't Receive AstraZeneca Shot
April 07 2021 - 11:25AM
Dow Jones News
The U.K.'s vaccines advisory body said Wednesday that a Covid-19
vaccine developed by AstraZeneca PLC shouldn't preferably be given
to patients aged under 30 following concerns that it may cause
potentially deadly blood clots in very rare instances.
Britain's Medicines and Healthcare Products Regulatory Agency
said more work is needed to firm up the link between the vaccine
and blood clots.
The AstraZeneca shot has faced questions about its efficacy and
potential side effects even as tens of millions of doses have been
administered following safety signoffs in more than 70
countries.
The British government said last week that 79 severe
blood-clotting cases were reported in the U.K. out of 20 million
administered doses of the Oxford-AstraZeneca vaccine, according to
data as of March 21. 19 of the people died, the regulator has told
reporters.
Britain is planning to give all adults a vaccine shot by the end
of July. Health regulators now recommend that under 30s receive
shots developed by Pfizer Inc. and BioNTech SE, Moderna Inc.
Write to Max Colchester at Max.Colchester@wsj.com
(END) Dow Jones Newswires
April 07, 2021 11:10 ET (15:10 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
From Mar 2024 to Apr 2024
AstraZeneca (NASDAQ:AZN)
Historical Stock Chart
From Apr 2023 to Apr 2024
